Complement factor H gene associations with end-stage kidney disease in African Americans

Nephrology Dialysis Transplantation

Volumn 29, Issue 7, 2014, Pages 1409-1414

  Bonomo, Jason A ^a   Palmer, Nicholette D ^a   Hicks, Pamela J ^a   Lea, Janice P ^b   Okusa, Mark D ^c   Langefeld, Carl D ^a   Bowden, Donald W ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

African Americans; CFH; end stage kidney disease; genetics; kidney disease

Indexed keywords

COMPLEMENT FACTOR H;

3' UNTRANSLATED REGION; ADULT; AFRICAN AMERICAN; APOLIPOPROTEIN L1 GENE; ARTICLE; COMPLEMENT FACTOR H GENE; CONTROLLED STUDY; END STAGE RENAL DISEASE; EXON; FEMALE; GENE; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CFH; END-STAGE KIDNEY DISEASE; GENETICS; KIDNEY DISEASE;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; COMPLEMENT FACTOR H; DNA; EXONS; FEMALE; GENOTYPE; HUMANS; INTRONS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84903823174     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu036     Document Type: Article

References (25)

1. Yachnin S. Functions and mechanism of action of complement. N Engl J Med 1966.; 274: 140-145
2. Zhao J, Wu H, Khosravi M et al.Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet 2011.; 7: E1002079
3. Alexander JJ, Pickering MC, Haas M et al. Complement factor h limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. J Am Soc Nephrol2005.; 16: 52-57
4. Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science2005.; 308: 385-389
5. Kiryluk K, Novak J, Gharavi AG. Pathogenesis of immunoglobulin A nephropathy: Recent insight from genetic studies. Annu Rev Med2013.; 64: 339-356
6. Gharavi AG, Kiryluk K, Choi M et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet2011.; 43: 321-327
7. Gale DP, de Jorge EG, Cook HT et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet2010.; 376: 794-801
8. Pickering MC, Cook HT, Warren J et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet2002.; 31: 424-428
9. Abrera-Abeleda MA, Nishimura C, Smith JL et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet2006.; 43: 582-589
10. Ying L, Katz Y, Schlesinger M et al. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet1999.; 65: 1538-1546
11. Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kidney Dis1995.; 25: 207-221
12. Zarif L, Covic A, Iyengar S et al. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant2000.; 15: 1801-1807
13. Bostrom MA, Kao WH, Li M et al. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis2012.; 59: 210-221
14. McDonough CW, Palmer ND, Hicks PJ et al. A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int2011.; 79: 563-572
15. Ng PC, Levy S, Huang J et al. Genetic variation in an individual human exome. PLoS Genet2008.; 4: E1000160
16. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science2010.; 329: 841-845
17. Wu MC, Lee S, Cai T et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet2011.; 89: 82-93
18. U.S. Renal Data System. USRDS 2012 Annual Data Report, Vol 1: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2012
19. Freedman BI, Langefeld CD, Lu L et al. Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet2011.; 7: E1002150
20. Kiryluk K, Li Y, Sanna-Cherchi S et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet2012.; 8: E1002765
21. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med2013.; 368: 2402-2414
22. Crews DC, Pfaff T, Powe NR. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin Nephrol2013.; 33: 468-475
23. Gopalakrishnan I, Iskandar SS, Daeihagh P et al. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol2011.; 42: 291-294
24. Moore I, Strain L, Pappworth I et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood2010.; 115: 379-387
25. Holmes LV, Strain L, Staniforth SJ et al. Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32. PLoS One2013.; 8: E60352